May 2026: Thirlwall Inquiry report delayed to at least September 2026 · six-baby inquests relisted to 2027 · CCRC review active · Shoo Lee Panel: no medical evidence of deliberate harm.
Outcome: Survived
Gestation: Twin 1; 33+2 weeks, 1.465 kg, severe intrauterine growth restriction
Sensitivity note: court-imposed lifelong anonymity covers every family. We use the court-assigned code only. See our families and witnesses sensitivity policy.
Insulin in feeds.
Method alleged: Exogenous insulin administered in enteral feeds.
Prosecution experts: Prof. Peter Hindmarsh (UCL / Great Ormond Street); Royal Liverpool biochemists.
Panel: hypoglycaemia was due to preterm birth and severe IUGR, and its medical management was inadequate. The insulin and C-peptide results do not prove exogenous insulin and are within the norm for preterm infants.
No fatal outcome. Panel conclusion: the hypoglycaemia was due to preterm birth and severe intrauterine growth restriction, and its medical management was inadequate; the insulin level and insulin/C-peptide ratio do not prove that exogenous insulin was used and are within the norm for preterm infants, who have different normative standards from healthy adults and older children. The Chase and Shannon bioengineering analysis annexed to the Panel report (covering Babies 6 and 12 — Children F and L) reaches the same conclusion by a separate route: C-peptide and potassium were not suppressed, the observed glucose was far higher than genuine exogenous insulin at the alleged levels would produce, and the immunoassay used is not of forensic quality.
Read the full long-form analysis →
Sources:
This page uses only the court-assigned code and publicly reported facts. The court imposed lifelong anonymity on every family; this site does not contact families and does not speculate about private circumstances.